|Company:||Roka Bioscience Inc.|
|Class Period:||Jul-17-14 to Nov-6-14|
|Lead Plaintiff Deadline:||Mar-8-15|
|Court:||District of New Jersey|
The complaint accuses the defendants of violations of the Securities Act of 1933 by virtue of Roka' failure to disclose in the Offering documents known trends and uncertainties about the demand for its Atlas instrument used to detect foodborne pathogens. According to the complaint after the Company' November 6 2014 announcement that in the third quarter of 2014 it had not placed any Atlas instruments in the marketplace and suffered an unexpected loss for the quarter the value of Atlas shares declined significantly.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.